Arkolith/Insider Trading/EGRX/Form 4

Tarriff Scott

CEO, Director, 10% OwnerEAGLE PHARMACEUTICALS, INC. (EGRX) · full profile →Form 4 · filed Oct 4, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$300K
Net Open-Market Flow
-$300K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 3, 2023Sell(S)710$15.11$11K567K
Oct 3, 2023Sell(S)10K$14.41$144K568K
Oct 2, 2023Sell(S)10K$15.23$145K578K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-052030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML